封面
市场调查报告书
商品编码
1869659

美国牙科膜和移植骨替代物市场规模、份额和趋势分析报告:按产品、应用和细分市场预测(2025-2033 年)

U.S. Dental Membrane And Bone Graft Substitutes Market Size, Share & Trends Analysis Report By Product, By Application, And Segment Forecasts, 2025 - 2033

出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10个工作天内

价格

市场规模与趋势:

2024年美国牙科膜和移植骨替代物市场规模为4.715亿美元,预计2033年将达到9.8068亿美元。

预计从 2025 年到 2033 年,该行业将以 8.61% 的复合年增长率成长。这一增长归因于牙周病患病率的上升、对人工植牙需求的增加以及人们对口腔卫生和美观意识的提高。

生物可吸收膜、异质骨移植和人工植牙等再生牙科技术的进步,正在改善治疗效果并加速癒合,从而拓宽这些材料在修復和美容牙科治疗中的应用范围。此外,人口老化加剧导致牙齿脱落和骨吸收率居高不下,以及微创治疗方法的日益普及,都进一步推动了市场成长。

牙科疾病的日益增多是推动行业成长的主要因素。牙周病、牙齿脱落和下颚骨劣化等疾病的发病率上升,促使人们对再生牙科手术的需求不断增长。这些疾病通常会导致骨吸收和软组织缺失,因此需要使用移植骨替代物和生物膜来恢復口腔结构和功能。此外,人工植牙作为首选的牙齿修復方式,其需求不断增长,也推动了这些生物材料的使用,以确保植入的稳定性并促进骨再生。随着口腔卫生意识提升的提高和先进牙科治疗的普及,预计国内对牙科生物膜和移植骨替代物的需求将稳步增长。

定期牙科检查对美国牙科膜和移植骨替代物市场的成长至关重要,因为这直接影响预防性和修復性牙科手术的需求。许多美国成年人每年都会进行牙科检查,这有助于及早发现牙周病、骨质流失和口腔结构缺陷,而这些情况通常需要使用移植材料和膜进行再生治疗。对预防保健的重视提高了患者对先进再生治疗的理解和接受度,从而支持了持续的市场需求。此外,由于外伤、感染疾病和拔牙等原因导致的非计划性紧急牙科就诊,也即时产生了对骨保存和骨增量的临床需求。稳定的常规病例和紧急病例维持了对牙科膜和移植骨替代物的持续需求,从而推动了美国市场的成长。

目录

第一章调查方法和范围

第二章执行摘要

第三章美国牙科膜和移植骨替代物市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场问题分析
    • 市场机会分析
  • 美国牙科膜和移植骨替代物市场分析工具
    • 产业分析—波特五力分析
    • PESTEL 分析

第四章美国牙科膜和移植骨替代物市场:按产品分類的估算和趋势分析

  • 细分仪表板
  • 产品变异分析
  • 美国牙科膜及移植骨替代物市场规模及趋势分析(按产品划分),2021-2033年
  • 移植骨替代物(BGS)
  • 牙科膜和软组织再生材料

第五章美国牙科膜和移植骨替代物市场:按应用分類的估算和趋势分析

  • 细分仪表板
  • 应用波动分析
  • 美国牙科膜及移植骨替代物市场规模及应用趋势分析(2021-2033年)
  • 齿槽嵴增高术
  • 鼻窦增高术
  • 牙周缺损的再生
  • 骨再生植入
  • 插座保护
  • 软组织再生
  • 其他的

第六章 竞争情势

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
    • 创新者
  • 供应商概况
    • Key company market share analysis, 2024
    • Dentsply Sirona
    • Bioteck SpA
    • Institut Straumann AG
    • Maxigen Biotech Inc.
    • Nobel Biocare Services AG(Envista)
    • Geistlich Pharma North America, Inc.
    • ZimVie Inc.
    • NovaBone(Halma)
    • Regenity
    • Medtronic
    • BioHorizons
    • Curasan, Inc.
    • DentiumUSA
    • Unicare Biomedical, Inc.
    • Neoss
Product Code: GVR-4-68040-206-5

Market Size & Trends:

The U.S. dental membrane and bone graft substitutes market size was valued at USD 471.50 million in 2024 and is anticipated to reach USD 980.68 million by 2033, growing at a CAGR of 8.61% from 2025 to 2033. This growth is attributed to the rising prevalence of periodontal diseases, increasing demand for dental implants, and growing awareness of oral health and aesthetics.

Advancements in regenerative dental technologies, such as bioresorbable membranes, xenografts, and alloplastic grafts, are improving treatment outcomes, accelerating healing, and expanding the use of these materials in both restorative and cosmetic dental procedures. Additionally, an aging population with higher rates of tooth loss and bone resorption, and the increasing availability of minimally invasive procedures, are further boosting market growth.

The rising burden of dental disorders is a key factor driving the growth of the industry. Increasing incidences of conditions such as periodontal disease, tooth loss, and jawbone deterioration are leading to a greater need for regenerative dental procedures. These disorders often result in bone resorption and soft tissue loss, creating the necessity for bone graft substitutes and barrier membranes to restore oral structure and function. Furthermore, the growing demand for dental implants as a preferred tooth replacement solution has intensified the use of these biomaterials to ensure implant stability and successful bone regeneration. As awareness of oral health and access to advanced dental treatments expand, the demand for dental membranes and bone graft substitutes is expected to rise steadily across the country.

Regular dental visits are pivotal in driving the U.S. dental membrane and bone graft substitutes market, as they directly influence the need for preventive and restorative dental procedures. Many U.S. adults undergo routine dental check-ups annually, promoting early detection of periodontal disease, bone loss, and structural oral defects that often necessitate regenerative interventions using grafts and membranes. This emphasis on preventive care also enhances patient awareness and acceptance of advanced regenerative solutions, supporting sustained market demand. Additionally, unplanned or emergency dental visits, such as those for trauma, infections, or extractions, create immediate clinical needs for bone preservation and augmentation. The steady flow of routine and emergency cases maintains a consistent demand for dental membranes and bone graft substitutes, strengthening market growth across the country.

U.S. Dental Membrane And Bone Graft Substitutes Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. dental membrane and bone graft substitutes market report on the basis of product and application:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Bone Graft Substitutes (BGS)
    • Allograft
    • Demineralized Bone Matrix
    • Others
    • Autograft
    • Xenograft
    • Bovine Derived
    • Porcine Derived
    • Others
    • Synthetic
    • Hydroxyapatite (HA)
    • Tricalcium Phosphate (TCP)
    • Bioactive Glass
    • Others
  • Dental Membranes and Soft Tissue Regeneration Materials
    • Resorbable Membranes
    • Bovine -derived collagen based
    • Porcine derived collagen based
    • Others
    • Non- Resorbable Membrane
    • Expanded PTFE (ePTFE)
    • Dense PTFE (dPTFE)
    • Titanium-Reinforced PTFE
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Ridge Augmentation
  • Sinus Lift
  • Periodontal Defect Regeneration
  • Implant Bone Regeneration
  • Socket Preservation
  • Soft Tissue Regeneration
  • Others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Application
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity price analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product Outlook
    • 2.2.2. Application Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Dental Membrane And Bone Graft Substitutes Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising burden of dental disorders
      • 3.2.1.2. Development of synthetic bone grafts
      • 3.2.1.3. Growing demand for aesthetic and restorative dental procedures
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of dental treatments
      • 3.2.2.2. Potential risks and complications associated with dental procedures
    • 3.2.3. Market Challenge Analysis
      • 3.2.3.1. Regulatory and approval complexities
      • 3.2.3.2. Economic and currency exchange risks
    • 3.2.4. Market Opportunity Analysis
      • 3.2.4.1. Increasing number of clinical trials
      • 3.2.4.2. Growing development & approvals of resorbable membranes
      • 3.2.4.3. Expansion into synthetic membrane
      • 3.2.4.4. Strategic partnerships & investment to enhance market presence
      • 3.2.4.5. Expansion opportunities in emerging economies
      • 3.2.4.6. Increasing demand for composite bone grafts
      • 3.2.4.7. Growing focus on 3D printed and custom grafts
  • 3.3. U.S. Dental Membrane And Bone Graft Substitutes Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. U.S. Dental Membrane And Bone Graft Substitutes Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Dental Membrane And Bone Graft Substitutes Market Product Movement Analysis
  • 4.3. U.S. Dental Membrane And Bone Graft Substitutes Market Size & Trend Analysis, by Product 2021 to 2033 (USD Million)
  • 4.4. Bone Graft Substitutes (BGS)
    • 4.4.1. Bone graft substitutes (BGS) market estimates and forecasts for 2021 to 2033 (USD Million)
      • 4.4.1.1. Allograft
        • 4.4.1.1.1. Allograft market estimates and forecasts for 2021 to 2033 (USD Million)
          • 4.4.1.1.1.1. Demineralized Bone Matrix
            • 4.4.1.1.1.1.1. Demineralized bone matrix market estimates and forecasts for 2021 to 2033 (USD Million)
          • 4.4.1.1.1.2. Others
            • 4.4.1.1.1.2.1. Others market estimates and forecasts for 2021 to 2033 (USD Million)
      • 4.4.1.2. Autograft
        • 4.4.1.2.1. Autograft market estimates and forecasts for 2021 to 2033 (USD Million)
      • 4.4.1.3. Xenograft
        • 4.4.1.3.1. Xenograft market estimates and forecasts for 2021 to 2033 (USD Million)
          • 4.4.1.3.1.1. Bovine Derived
            • 4.4.1.3.1.1.1. Bovine derived market estimates and forecasts for 2021 to 2033 (USD Million)
          • 4.4.1.3.1.2. Porcine Derived
            • 4.4.1.3.1.2.1. Porcine derived market estimates and forecasts for 2021 to 2033 (USD Million)
          • 4.4.1.3.1.3. Others
            • 4.4.1.3.1.3.1. Others market estimates and forecasts for 2021 to 2033 (USD Million)
      • 4.4.1.4. Synthetic
        • 4.4.1.4.1. Synthetic market estimates and forecasts for 2021 to 2033 (USD Million)
          • 4.4.1.4.1.1. Hydroxyapatite (HA)
            • 4.4.1.4.1.1.1. Hydroxyapatite (HA) market estimates and forecasts for 2021 to 2033 (USD Million)
          • 4.4.1.4.1.2. Tricalcium Phosphate (TCP)
            • 4.4.1.4.1.2.1. Tricalcium phosphate (TCP) market estimates and forecasts for 2021 to 2033 (USD Million)
          • 4.4.1.4.1.3. Bioactive Glass
            • 4.4.1.4.1.3.1. Bioactive glass market estimates and forecasts for 2021 to 2033 (USD Million)
          • 4.4.1.4.1.4. Others
            • 4.4.1.4.1.4.1. Others market estimates and forecasts for 2021 to 2033 (USD Million)
  • 4.5. Dental Membranes and Soft Tissue Regeneration Materials
    • 4.5.1. Dental membranes and soft tissue regeneration materials market estimates and forecasts for 2021 to 2033 (USD Million)
      • 4.5.1.1. Resorbable membranes
        • 4.5.1.1.1. Resorbable membranes market estimates and forecasts for 2021 to 2033 (USD Million)
          • 4.5.1.1.1.1. Bovine -derived collagen based
            • 4.5.1.1.1.1.1. Bovine -derived collagen based market estimates and forecasts for 2021 to 2033 (USD Million)
          • 4.5.1.1.1.2. Porcine derived collagen based
            • 4.5.1.1.1.2.1. Porcine derived collagen based market estimates and forecasts for 2021 to 2033 (USD Million)
          • 4.5.1.1.1.3. Others
            • 4.5.1.1.1.3.1. Others market estimates and forecasts for 2021 to 2033 (USD Million)
      • 4.5.1.2. Non resorbable membranes
        • 4.5.1.2.1. Non resorbable membranes market estimates and forecasts for 2021 to 2033 (USD Million)
          • 4.5.1.2.1.1. Expanded PTFE (ePTFE)
            • 4.5.1.2.1.1.1. Expanded PTFE (ePTFE) market estimates and forecasts for 2021 to 2033 (USD Million)
          • 4.5.1.2.1.2. Dense PTFE (dPTFE)
            • 4.5.1.2.1.2.1. Dense PTFE (dPTFE) market estimates and forecasts for 2021 to 2033 (USD Million)
          • 4.5.1.2.1.3. Titanium-Reinforced PTFE
            • 4.5.1.2.1.3.1. Titanium-reinforced PTFE market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 5. U.S. Dental Membrane And Bone Graft Substitutes Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Dental Membrane And Bone Graft Substitutes Market Application Movement Analysis
  • 5.3. U.S. Dental Membrane And Bone Graft Substitutes Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 5.4. Ridge Augmentation
    • 5.4.1. Ridge augmentation market estimates and forecast 2021 to 2033 (USD Million)
  • 5.5. Sinus Lift
    • 5.5.1. Sinus lift market estimates and forecast 2021 to 2033 (USD Million)
  • 5.6. Periodontal Defect Regeneration
    • 5.6.1. Periodontal defect regeneration market estimates and forecast 2021 to 2033 (USD Million)
  • 5.7. Implant Bone Regeneration
    • 5.7.1. Implant bone regeneration market estimates and forecast 2021 to 2033 (USD Million)
  • 5.8. Socket Preservation
    • 5.8.1. Socket preservation market estimates and forecasts for 2021 to 2033 (USD Million)
  • 5.9. Soft Tissue Regeneration
    • 5.9.1. Soft tissue regeneration market estimates and forecast 2021 to 2033 (USD Million)
  • 5.10. Others
    • 5.10.1. Others market estimates and forecast 2021 to 2033 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company/Competition Categorization
    • 6.2.1. Innovators
  • 6.3. Vendor Landscape
    • 6.3.1. Key company market share analysis, 2024
    • 6.3.2. Dentsply Sirona
      • 6.3.2.1. Company overview
      • 6.3.2.2. Financial performance
      • 6.3.2.3. Usage benchmarking
      • 6.3.2.4. Strategic initiatives
    • 6.3.3. Bioteck S.p.A.
      • 6.3.3.1. Company overview
      • 6.3.3.2. Financial performance
      • 6.3.3.3. Usage benchmarking
      • 6.3.3.4. Strategic initiatives
    • 6.3.4. Institut Straumann AG
      • 6.3.4.1. Company overview
      • 6.3.4.2. Financial performance
      • 6.3.4.3. Usage benchmarking
      • 6.3.4.4. Strategic initiatives
    • 6.3.5. Maxigen Biotech Inc.
      • 6.3.5.1. Company overview
      • 6.3.5.2. Financial performance
      • 6.3.5.3. Usage benchmarking
      • 6.3.5.4. Strategic initiatives
    • 6.3.6. Nobel Biocare Services AG (Envista)
      • 6.3.6.1. Company overview
      • 6.3.6.2. Financial performance
      • 6.3.6.3. Usage benchmarking
      • 6.3.6.4. Strategic initiatives
    • 6.3.7. Geistlich Pharma North America, Inc.
      • 6.3.7.1. Company overview
      • 6.3.7.2. Financial performance
      • 6.3.7.3. Usage benchmarking
      • 6.3.7.4. Strategic initiatives
    • 6.3.8. ZimVie Inc.
      • 6.3.8.1. Company overview
      • 6.3.8.2. Financial performance
      • 6.3.8.3. Usage benchmarking
      • 6.3.8.4. Strategic initiatives
    • 6.3.9. NovaBone (Halma)
      • 6.3.9.1. Company overview
      • 6.3.9.2. Financial performance
      • 6.3.9.3. Usage benchmarking
      • 6.3.9.4. Strategic initiatives
    • 6.3.10. Regenity
      • 6.3.10.1. Company overview
      • 6.3.10.2. Financial performance
      • 6.3.10.3. Usage benchmarking
      • 6.3.10.4. Strategic initiatives
    • 6.3.11. Medtronic
      • 6.3.11.1. Company overview
      • 6.3.11.2. Financial performance
      • 6.3.11.3. Usage benchmarking
      • 6.3.11.4. Strategic initiatives
    • 6.3.12. BioHorizons
      • 6.3.12.1. Company overview
      • 6.3.12.2. Financial performance
      • 6.3.12.3. Usage benchmarking
      • 6.3.12.4. Strategic initiatives
    • 6.3.13. Curasan, Inc.
      • 6.3.13.1. Company overview
      • 6.3.13.2. Financial performance
      • 6.3.13.3. Usage benchmarking
      • 6.3.13.4. Strategic initiatives
    • 6.3.14. DentiumUSA
      • 6.3.14.1. Company overview
      • 6.3.14.2. Financial performance
      • 6.3.14.3. Usage benchmarking
      • 6.3.14.4. Strategic initiatives
    • 6.3.15. Unicare Biomedical, Inc.
      • 6.3.15.1. Company overview
      • 6.3.15.2. Financial performance
      • 6.3.15.3. Usage benchmarking
      • 6.3.15.4. Strategic initiatives
    • 6.3.16. Neoss
      • 6.3.16.1. Company overview
      • 6.3.16.2. Financial performance
      • 6.3.16.3. Usage benchmarking
      • 6.3.16.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 U.S. dental membrane and bone graft substitutes market, by country, 2021 - 2033 (USD Million)
  • Table 4 U.S. dental membrane and bone graft substitutes market, by product, 2021 - 2033 (USD Million)
  • Table 5 U.S. dental membrane and bone graft substitutes market, by application, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 U.S. Dental Membrane And Bone Graft Substitutes Market, Market Segmentation
  • Fig. 7 Market Driver Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Analysis (Current & Future Impact)
  • Fig. 9 Market Opportunity Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Dental membrane and bone graft substitutes market: Product movement analysis
  • Fig. 14 Bone Graft Substitutes (BGS) Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 15 Allograft Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 16 Demineralized Bone Matrix Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 17 Others Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 18 Autograft Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 19 Xenograft Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 20 Bovine Derived Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 21 Porcine Derived Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 22 Others Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 23 Synthetic Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 24 Hydroxyapatite (HA) Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 25 Tricalcium Phosphate (TCP) Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 26 Bioactive Glass Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 27 Others Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 28 Dental Membranes and Soft Tissue Regeneration Materials Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 29 Resorbable Membranes Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 30 Bovine -Derived Collagen Based Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 31 Porcine Derived Collagen Based Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 32 Others Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 33 Non Resobable Membranes Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 34 Expanded PTFE (ePTFE) Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 35 Dense PTFE (dPTFE) Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 36 Titanium-Reinforced PTFE Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 37 Dental Membrane And Bone Graft Substitutes Market: Application Movement Analysis
  • Fig. 38 Ridge Augmentation Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 39 Sinus Lift Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 40 Periodontal Defect Regeneration Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 41 Implant Bone Regeneration Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 42 Socket Preservation Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 43 Soft Tissue Regeneration Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 44 Others Market Estimates and Forecast, 2021 - 2033 (USD Million)